SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-056375
Filing Date
2021-11-12
Accepted
2021-11-12 06:02:29
Documents
16
Period of Report
2021-11-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ktra-8k_20211108.htm   iXBRL 8-K 57719
2 EX-10.1 ktra-ex101_6.htm EX-10.1 135840
3 EX-10.2 ktra-ex102_7.htm EX-10.2 140830
4 GRAPHIC g4xv3s51sgic000002.jpg GRAPHIC 5293
5 GRAPHIC g4xv3s51sgic000001.jpg GRAPHIC 5293
  Complete submission text file 0001564590-21-056375.txt   548328

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ktra-20211108.xsd EX-101.SCH 5925
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ktra-20211108_lab.xml EX-101.LAB 19749
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ktra-20211108_pre.xml EX-101.PRE 12258
9 EXTRACTED XBRL INSTANCE DOCUMENT ktra-8k_20211108_htm.xml XML 3527
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 211398851
SIC: 2834 Pharmaceutical Preparations